Shots:
The US FDA has approved initiation of the P-III (OASIS) trial evaluating OsteoAdapt SP as an alternative to autologous & allograft bone graft in TLIF, ALIF, and LLIF procedures for symptomatic degenerative lumbosacral spine disease
This approval builds on prior clinical experience in ~100 participants & expanded enrollment in Australia & Israel, while the…
